| 1998 |
PIGC (PIG-C) forms a protein complex in the endoplasmic reticulum membrane with PIG-A, PIG-H, and hGPI1 (four mammalian gene products). This complex has GPI-GlcNAc transferase (GPI-GnT) activity in vitro, catalyzing transfer of N-acetylglucosamine from UDP-GlcNAc to phosphatidylinositol as the first step of GPI biosynthesis. PIG-L, involved in the second step, did not associate with this complex. Bovine PI was utilized ~100-fold more efficiently than soybean PI, suggesting the complex recognizes the fatty acyl chains of PI. |
Co-immunoprecipitation of complex components, in vitro GPI-GnT enzymatic activity assay, substrate specificity analysis with different PI sources |
The EMBO journal |
High |
9463366
|
| 1996 |
PIG-C is a 297 amino-acid membrane protein localized to the endoplasmic reticulum and is the human homologue of yeast GPI2. It is one of at least three mammalian genes (PIG-A, PIG-H, PIG-C) required for the first step of GPI biosynthesis (GlcNAc transfer to PI). |
Molecular cloning, sequence homology analysis, subcellular localization by membrane fractionation/ER marker co-localization, functional complementation |
Biochemical and biophysical research communications |
Medium |
8806613
|
| 1997 |
The PIGC gene is intronless and maps to chromosome 1q23-q25. A processed pseudogene (PIGCP1) was identified and mapped to chromosome 11p12-p13. The autosomal localization of PIGC (unlike the X-linked PIGA) is consistent with the requirement for two somatic mutations to cause PNH. |
Genomic cloning, chromosomal mapping by fluorescence in situ hybridization (FISH), gene structure analysis |
Genomics |
Medium |
9325057
|
| 1995 |
Yeast GPI2 (the ortholog of mammalian PIGC) is required for GlcNAc-phosphatidylinositol synthesis (first step of GPI biosynthesis). Loss-of-function gpi2 mutants lack in vitro GlcNAc-PI synthetic activity. Overexpression of GPI2 partially suppresses the gpi1 temperature-sensitive mutant, suggesting physical or functional interaction between Gpi1 and Gpi2 proteins in vivo. GPI2 is essential for vegetative growth. |
Temperature-sensitive mutant isolation, in vitro GlcNAc-PI synthesis assay, gene disruption (null mutant), genetic suppression (overexpression rescue of gpi1 ts mutant) |
The Journal of biological chemistry |
High |
7768896
|
| 2016 |
Disease-causing mutations in human PIGC (p.L189W, p.L212P, p.R21X) result in reduced surface expression of GPI-anchored proteins (CD90, CD48, FLAER in transfected PIGC-defective mouse cells; CD16, CD14, CD55, CD59 in patient leukocytes), confirming that PIGC function is required for normal GPI anchor biosynthesis in vivo. |
Transfection of PIGC variants into PIGC-defective mouse cells, flow cytometry for GPI-anchored protein surface expression; patient leukocyte analysis by flow cytometry |
Journal of medical genetics |
High |
27694521
|
| 2021 |
In Trypanosoma brucei, TbGPI2 (ortholog of PIGC) is a subunit of the GPI-GlcNAc transferase complex; its elimination reduces (but does not abolish) GPI-GlcNAc transferase activity and disrupts the complex architecture (loss of TbGPI1 subunit). TbGPI2-null parasites show underglycosylated GPI anchors on procyclins, and TbGPI2 localizes not only to the ER but also to the Golgi apparatus, suggesting a noncanonical role in Golgi-localized GPI anchor modification. |
Genetic knockout (TbGPI2-null parasites), in vitro GPI-GlcNAc transferase activity assay, co-immunoprecipitation of complex components, GPI glycan structural analysis, immunofluorescence microscopy |
The Journal of biological chemistry |
Medium |
34284059
|
| 2014 |
In S. cerevisiae, ScGpi2 (PIGC ortholog) physically interacts with and negatively modulates Ras signaling. Functional complementation studies showed that ScGPI2 and CaGPI2 (from C. albicans) are not fully interchangeable: CaGPI2 cannot restore ScGPI2-null growth defects, and ScGPI2 cannot restore CaGPI2 heterozygote GPI-GnT activity or cell wall integrity. However, ScGPI2 can restore CaERG11 (lanosterol demethylase) levels in the CaGPI2 heterozygote, acting through CaGPI19, independent of GPI-GnT complex interactions. |
Functional complementation (cross-species expression), GPI-GnT activity assay, cell wall integrity assay, filamentation assay, western blot for CaERG11 levels |
Glycoconjugate journal |
Medium |
25117514
|
| 2021 |
Silencing of PIGC in HepG2 hepatocellular carcinoma cells inhibits proliferation and migration and causes G0/G1 cell cycle arrest, associated with reduced expression of cyclinD1, CDK2, CDK4, and CDK6. Overexpression of PIGC in Hcclm3 cells produces the opposite effects. |
siRNA knockdown and overexpression in cancer cell lines, cell proliferation assay, migration assay, flow cytometry for cell cycle analysis, western blot for cell cycle regulators |
Journal of hepatocellular carcinoma |
Low |
33854986
|
| 2025 |
Biallelic PIGC variants in patients result in reduced cell-surface levels of GPI-anchored proteins, as demonstrated by flow cytometry on samples from probands and cellular models, confirming that dysfunctional PIGC causes defective GPI-AP biosynthesis. |
Flow cytometry for GPI-AP surface expression in patient-derived samples and cellular models; in silico structural modelling (AlphaFold2) of variants; genome/exome sequencing |
European journal of human genetics |
Medium |
40962973
|